掠夺性期刊时代的科学诚信:主编座谈会的启示。

IF 6.8 2区 医学 Q1 PHARMACOLOGY & PHARMACY British Journal of Pharmacology Pub Date : 2024-06-09 DOI:10.1111/bph.16480
Zoltan Benyó, Emilio Clementi, Serge Cremers, Beáta Dávid, Tomasz Guzik, Gerd Heusch, Michael Jarvis, Kaan Orhan, Roland Seifert, József Tímár, Zoltan Ungvari, Péter Ferdinandy
{"title":"掠夺性期刊时代的科学诚信:主编座谈会的启示。","authors":"Zoltan Benyó,&nbsp;Emilio Clementi,&nbsp;Serge Cremers,&nbsp;Beáta Dávid,&nbsp;Tomasz Guzik,&nbsp;Gerd Heusch,&nbsp;Michael Jarvis,&nbsp;Kaan Orhan,&nbsp;Roland Seifert,&nbsp;József Tímár,&nbsp;Zoltan Ungvari,&nbsp;Péter Ferdinandy","doi":"10.1111/bph.16480","DOIUrl":null,"url":null,"abstract":"<p>In recent years, the academic community has faced a growing threat from predatory journals. These are publications that prioritize profit over quality scholarship and compromise the integrity of scientific discourse. Predatory journals often bypass rigorous peer review processes, creating a platform for substandard and sometimes fraudulent research. The proliferation of such journals not only undermines trust in scientific publications but also poses serious challenges for researchers who are trying to responsibly share their findings.</p><p>Recognizing these pressing issues, Semmelweis University held a symposium on 16 November 2023, titled ‘Science Integrity in the Era of Predator Journals’. This event was a response to growing concerns about academic publishing. It brought together editors in chief (EiCs) from 14 top journals to discuss critical topics. These included using AI to detect publication fraud, the identification of AI-generated papers, combating paper mills, the necessity of robust submission and review processes and the importance of author identity and conflict of interest vetting.</p><p>This editorial offers a thorough summary of the symposium's discussions. It highlights the collaborative efforts to improve publication standards and reinforce ethical practices in scientific research. Through shared insights and strategies, the participants tackled the complex challenges posed by predatory journals, setting a course for sustained integrity in the dissemination of scientific knowledge.</p><p>Professor Péter Ferdinandy, the EiC of the <i>British Journal of Pharmacology</i> (<i>BJP</i>) and host of the event, presented how he plans to continue the long tradition of <i>BJP</i> excellence while improving overall publication quality as well as the experience of both authors and editors. In this regard, steps have been taken to simplify the <i>BJP</i> publication guidelines and improve turnaround times at every step of the review and publication process (Papapetropoulos et al., <span>2023</span>). He also highlighted that <i>BJP</i> editors in partnership with the <i>BJP</i> publisher Wiley are taking aggressive steps to combat publication fraud. These steps have involved the development of an efficient pipeline to handle ethics investigations as well as the retention of a consulting editor dedicated to matters of research integrity. As a result, ethical concerns raised internally or by third parties are dealt with in a much timelier manner with corrective action being rapidly implemented where necessary.</p><p>The EiC of the <i>British Journal of Clinical Pharmacology</i> (<i>BJCP</i>—a sister journal of <i>BJP</i> also published by Wiley), Professor Serge Cremers, delved into many issues surrounding the maintenance of publication integrity. As the <i>BJCP</i> deals with many clinical studies, a strong emphasis was placed on resolving the inherent conflicts of interest that arise between the economics of drug development and patient well-being that may bias the publication of clinical trial results. The <i>BJCP</i> requires all submissions to strongly adhere to good clinical practice (GCP) guidelines, have internal review board (IRB) approval and disclose the identity of the physician conducting the trial. The <i>BJCP</i> also utilizes AI-powered systems provided by Wiley for the detection of plagiarism, image manipulation and other forms of fraud. However, <i>BJCP</i> still heavily relies on its editors and reviewers to detect fraud and admits that despite all the safeguards in-place, intercepting all forms of deceit is not perfect.</p><p>The EiC of <i>Pharmacology Research &amp; Perspectives</i> (<i>PR&amp;P</i>—a collaborative Open Access journal of the British Pharmacology Society [BPS], the American Society for Pharmacology and Experimental Therapeutics and Wiley), Michael Jarvis, highlighted ongoing strategic priorities of publishing pharmacological methods, research replication studies and negative research findings and providing a forum for early career researchers. While only in its 11th year, <i>PR&amp;P</i> provides an important, geographically inclusive, venue for publication of scientifically rigorous papers that directly address issues of research reliability (Jarvis et al., <span>2023</span>). Like <i>BJP</i> and <i>BJCP</i>, all papers and data submitted to <i>PR&amp;P</i> are initially screened using Wiley's AL-powered manuscript integrity system.</p><p>Professor Tomasz Guzik, the EiC of <i>Cardiovascular Research</i>, introduced the meeting attendees to the concepts of ‘Open Science’. This is an initiative that strives to improve the trust and access to scientific knowledge by implementing ‘open’ processes at every step of the way from data generation and analysis through publication and dissemination. Pillars of this initiative are open data, open access publication, open source software, open evaluation and open educational resources. This model was also avidly supported by the EiC of <i>Oral Radiology</i>, Professor Kaan Orhan, who emphasized the need for detailed methodological reporting as well as raw data and source code sharing. Prof. Guzik highlighted data sharing tools such as GO Fair that aims to make raw data easily accessible to both humans and computers, the preprint servers bioRxiv and medRxiv and repositories such as the UK Biobank as a model for open access big data dissemination. He also tackled the role of AI within the open science model, addressing the good and the bad. The advantages of AI highlighted were manifold including its speed and efficiency, potential to reduce human-led analysis bias, enhanced pattern recognition, improved reproducibility and generation of robust predictive models. The drawbacks discussed included AI output quality control, intellectual property and data privacy issues, the introduction and perpetuation of analysis biases and the erosion of human user critical thinking. Although there are manifold benefits to the ‘Open Science’ model, the EiC of <i>Pharmacology Research &amp; Perspectives</i>, Dr. Michael Jarvis, highlighted that the ethos is directly fuelling the rise of paper mills, predatory journals and a sidelining of the peer review process that is making it more challenging to identify high quality publications (Jarvis, <span>2024</span>; Jarvis &amp; Williams, <span>2016</span>).</p><p>Professor Roland Seifert, the EiC of the oldest pharmacology journal <i>Naunyn-Schmiedebergs Arch Pharmacol</i> (<i>NSAP</i>) founded in 1873, gave a detailed account of their ongoing war against the fraudulent publications generated by paper mills. Prof. Seifert detailed a three-step approach used by <i>NSAP</i> to identify fake papers which included checking <i>NSAP</i> rejected and withdrawn manuscripts against published literature using text mining tools, comparing the author lists of rejected/withdrawn <i>NSAP</i> submissions with their subsequently published versions in other journals and finally manual verification that the submission is the same if the author lists differed extensively. In this way, <i>NSAP</i> evaluated 2056 papers rejected/withdrawn between 2015 and 2021, finding that 952 were published elsewhere. Eleven of these 952 had radically different author lists than the <i>NSAP</i> submitted versions, and 10 of these were ultimately deemed to be fake papers (Wittau et al., <span>2024</span>). Notably, the vast majority of the authors on these fake papers were Chinese highlighting paper mills as a geographic problem (Wittau &amp; Seifert, <span>2024</span>). Disappointingly, the journals that published the 10 fake papers have yet to take substantiative corrective action, highlighting that a massive change is necessary in how journals cooperate to maintain the scientific record. To combat paper mills, <i>NSAP</i> proposes the establishment of a database where all journals would submit their received manuscripts to enable cross-checking and flagging of potentially fraudulent papers.</p><p>The best way to prevent overt publication fraud is to detect it at its earliest stages. To this end, the EiCs of <i>Pathology Oncology Research</i> (Dr. József Tímár), <i>Physiology International</i> (Dr. Zoltan Benyó), <i>Pharmacological Research</i> (Professor Emilio Clementi) and the <i>European Journal of Mental Health</i> (Professor Dávid Beáta) detailed the criteria they use to screen submissions. Immediate warning signs of potential fraud include all of the authors on a manuscript having 0–2 previous publications, use of non-institutional email addresses, the claimed institute not having an easily identified homepage, study funding undefined yet the submission contains expensive experiments and if the authors cannot suggest potential reviewers for their work. To help validate author identity, it is suggested that ORCIDs as well as work email addresses should be required. At the level of the manuscript itself, plagiarism should be screened for stringently with 0% text overlap occurring in the results section and &lt;20% text overlap overall. Images should be checked for signs of manipulation and raw data such as uncut western blots submitted along with the manuscript. Additionally, only research that is ethically approved should be under consideration for publication that requires the submission of original internal review board (IRB) documents demonstrating study approval. Author contributions should also be declared using internationally recognized systems such as ‘Contributor Roles Taxonomy’ (CRediT) and the International Committee of Medical Journal Editors Acknowledgements criteria.</p><p>The process of peer review is integral to the maintenance of scientific integrity. A general consensus of the meeting participants was that the double-blind review process is optimal for unbiased assessment and should involve at least two expert reviewers. Recognizing the wide scope of their portfolio, it is recommended that journals develop a robust network of consulting editors. These editors, specialists in key subfields, can provide their expertise on an as-needed basis, ensuring high-quality and relevant evaluations.</p><p>A consensus view to emerge from this meeting was the need to foster a sense of community among authors, editors and reviewers. Indeed, if everyone has a direct stake in scientific integrity and is personally motivated to help maintain it, there is much less room for fraud to take root. This is especially relevant in the pharmacology research community that has a well-established history of requiring the reporting of clear and comprehensive reporting of research methodology and analysis (Jarvis, <span>2024</span>). Professor Orhan correctly identified that this begins on the institute level that have to do much more to promote an environment of scientific cooperation and knowledge sharing. He further proposed that specific education at the institute level in publication ethics could go a long way to curbing unintentional ethical lapses and greatly improve outcomes for both authors, journals and ultimately the scientific record.</p><p>Another crucial element in safeguarding scientific integrity is the continued support and development of society-affiliated journals as exemplified by ASPET, BPS and DGPT. These society-based journals benefit immensely from the interconnected community of members who regularly engage at society meetings and conferences. Such interactions facilitate a deeper understanding and familiarity with ongoing research in the field. When editors and reviewers are active participants in these scientific discussions, they gain first-hand insight into the nuances of the research and the reliability of the researchers themselves. This familiarity helps in making more informed decisions during the peer review process. Moreover, the society meetings serve as platforms for vibrant scientific debate, allowing potential issues and breakthroughs to be scrutinized collaboratively. By fostering a community that is both knowledgeable and engaged, society-affiliated journals inherently promote a culture of transparency and rigorous scholarly review, thereby enhancing the overall quality and credibility of published research. Additionally, these journals can further support the society's community-building efforts by publishing meeting proceedings (Murphy et al., <span>2022</span>; Whitehead et al., <span>2022</span>). This not only captures the spirit of the scientific debates held at these gatherings but also serves as a valuable archival resource that chronicles the progression of thought and discovery within the field.</p><p>Professor Zoltan Ungvari of <i>GeroScience</i> highlighted an innovative approach to build community within the journal's network. As part of the American Aging Association (AGE), <i>GeroScience</i> utilizes members with high scientific standing from AGE to serve as handling editors, thereby enhancing the quality and depth of the feedback provided to authors. The journal also has instituted a mentorship program where seasoned reviewers guide less experienced ones, promoting a rigorous review culture. This system has not only increased reviewer reliability but also achieved a remarkable 96% author satisfaction rate, demonstrating the efficacy of community-oriented approaches in scientific publishing.</p><p>Efforts to foster proactive engagement among junior scientists are a vital part of community-building within scientific societies. One particularly effective strategy highlighted by Professor Ungvari is the provision of incentives such as publication awards. These awards are given to junior scientists who author high-impact papers published in the society-affiliated journal. Additionally, award recipients are invited to attend the annual meeting of the society and are often recruited for the journal's peer reviewer training program. This involvement not only provides them with a platform to share their work and engage directly with leading figures in the field but also integrates them into the journal's operational processes, including open meetings held at the society's annual gatherings. Such initiatives strengthen the bond between the journal and the society while reinforcing the community as a whole. By supporting the development of emerging scientists in these ways, the journal and the society cultivate a rich environment of collaboration and scholarly exchange, enhancing the scientific community from the ground up.</p><p>Notwithstanding all emphasis on scientific integrity and all efforts to prevent publication of fraudulent studies, authors and editors must also cooperate to set the record straight and avoid a positive publication bias in a specific field (Skyschally et al., <span>2024</span>). Professor Gerd Heusch, EiC of <i>Basic Research in Cardiology</i> (<i>BRiC</i>), proposed that authors are encouraged to use a prospective, power analysis-based study design with appropriate randomization and blinding of investigators wherever possible. Editors should make sure that neutral studies and studies which contradict prior published data are published in equal right with positive, novel studies (Jarvis et al., <span>2023</span>).</p><p>In conclusion, the symposium at Semmelweis University marks a significant milestone in the ongoing battle against predatory journals and the broader challenges facing scientific publishing. The collaborative efforts discussed, and the strategies developed during the event underline a collective commitment to upholding scientific integrity. The measures outlined by the symposium's participants, from enhancing peer review to fostering transparency through society-affiliated journals and social media, set a path toward a more accountable and reliable scientific discourse. A key takeaway is the crucial need for non-predatory journals to form a united front, sharing resources, data and best practices to effectively combat the spread of unethical publications. This cooperation is essential not only for maintaining high standards within individual journals but also for fostering a global academic environment resistant to fraud and misconduct. As the academic community continues to evolve, the importance of robust review processes, community engagement and the implementation of innovative tools such as AI cannot be overstated. By continuing to engage, educate and innovate, we can ensure that scientific advancements remain a beacon of truth and progress.</p>","PeriodicalId":9262,"journal":{"name":"British Journal of Pharmacology","volume":null,"pages":null},"PeriodicalIF":6.8000,"publicationDate":"2024-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bph.16480","citationCount":"0","resultStr":"{\"title\":\"Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium\",\"authors\":\"Zoltan Benyó,&nbsp;Emilio Clementi,&nbsp;Serge Cremers,&nbsp;Beáta Dávid,&nbsp;Tomasz Guzik,&nbsp;Gerd Heusch,&nbsp;Michael Jarvis,&nbsp;Kaan Orhan,&nbsp;Roland Seifert,&nbsp;József Tímár,&nbsp;Zoltan Ungvari,&nbsp;Péter Ferdinandy\",\"doi\":\"10.1111/bph.16480\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>In recent years, the academic community has faced a growing threat from predatory journals. These are publications that prioritize profit over quality scholarship and compromise the integrity of scientific discourse. Predatory journals often bypass rigorous peer review processes, creating a platform for substandard and sometimes fraudulent research. The proliferation of such journals not only undermines trust in scientific publications but also poses serious challenges for researchers who are trying to responsibly share their findings.</p><p>Recognizing these pressing issues, Semmelweis University held a symposium on 16 November 2023, titled ‘Science Integrity in the Era of Predator Journals’. This event was a response to growing concerns about academic publishing. It brought together editors in chief (EiCs) from 14 top journals to discuss critical topics. These included using AI to detect publication fraud, the identification of AI-generated papers, combating paper mills, the necessity of robust submission and review processes and the importance of author identity and conflict of interest vetting.</p><p>This editorial offers a thorough summary of the symposium's discussions. It highlights the collaborative efforts to improve publication standards and reinforce ethical practices in scientific research. Through shared insights and strategies, the participants tackled the complex challenges posed by predatory journals, setting a course for sustained integrity in the dissemination of scientific knowledge.</p><p>Professor Péter Ferdinandy, the EiC of the <i>British Journal of Pharmacology</i> (<i>BJP</i>) and host of the event, presented how he plans to continue the long tradition of <i>BJP</i> excellence while improving overall publication quality as well as the experience of both authors and editors. In this regard, steps have been taken to simplify the <i>BJP</i> publication guidelines and improve turnaround times at every step of the review and publication process (Papapetropoulos et al., <span>2023</span>). He also highlighted that <i>BJP</i> editors in partnership with the <i>BJP</i> publisher Wiley are taking aggressive steps to combat publication fraud. These steps have involved the development of an efficient pipeline to handle ethics investigations as well as the retention of a consulting editor dedicated to matters of research integrity. As a result, ethical concerns raised internally or by third parties are dealt with in a much timelier manner with corrective action being rapidly implemented where necessary.</p><p>The EiC of the <i>British Journal of Clinical Pharmacology</i> (<i>BJCP</i>—a sister journal of <i>BJP</i> also published by Wiley), Professor Serge Cremers, delved into many issues surrounding the maintenance of publication integrity. As the <i>BJCP</i> deals with many clinical studies, a strong emphasis was placed on resolving the inherent conflicts of interest that arise between the economics of drug development and patient well-being that may bias the publication of clinical trial results. The <i>BJCP</i> requires all submissions to strongly adhere to good clinical practice (GCP) guidelines, have internal review board (IRB) approval and disclose the identity of the physician conducting the trial. The <i>BJCP</i> also utilizes AI-powered systems provided by Wiley for the detection of plagiarism, image manipulation and other forms of fraud. However, <i>BJCP</i> still heavily relies on its editors and reviewers to detect fraud and admits that despite all the safeguards in-place, intercepting all forms of deceit is not perfect.</p><p>The EiC of <i>Pharmacology Research &amp; Perspectives</i> (<i>PR&amp;P</i>—a collaborative Open Access journal of the British Pharmacology Society [BPS], the American Society for Pharmacology and Experimental Therapeutics and Wiley), Michael Jarvis, highlighted ongoing strategic priorities of publishing pharmacological methods, research replication studies and negative research findings and providing a forum for early career researchers. While only in its 11th year, <i>PR&amp;P</i> provides an important, geographically inclusive, venue for publication of scientifically rigorous papers that directly address issues of research reliability (Jarvis et al., <span>2023</span>). Like <i>BJP</i> and <i>BJCP</i>, all papers and data submitted to <i>PR&amp;P</i> are initially screened using Wiley's AL-powered manuscript integrity system.</p><p>Professor Tomasz Guzik, the EiC of <i>Cardiovascular Research</i>, introduced the meeting attendees to the concepts of ‘Open Science’. This is an initiative that strives to improve the trust and access to scientific knowledge by implementing ‘open’ processes at every step of the way from data generation and analysis through publication and dissemination. Pillars of this initiative are open data, open access publication, open source software, open evaluation and open educational resources. This model was also avidly supported by the EiC of <i>Oral Radiology</i>, Professor Kaan Orhan, who emphasized the need for detailed methodological reporting as well as raw data and source code sharing. Prof. Guzik highlighted data sharing tools such as GO Fair that aims to make raw data easily accessible to both humans and computers, the preprint servers bioRxiv and medRxiv and repositories such as the UK Biobank as a model for open access big data dissemination. He also tackled the role of AI within the open science model, addressing the good and the bad. The advantages of AI highlighted were manifold including its speed and efficiency, potential to reduce human-led analysis bias, enhanced pattern recognition, improved reproducibility and generation of robust predictive models. The drawbacks discussed included AI output quality control, intellectual property and data privacy issues, the introduction and perpetuation of analysis biases and the erosion of human user critical thinking. Although there are manifold benefits to the ‘Open Science’ model, the EiC of <i>Pharmacology Research &amp; Perspectives</i>, Dr. Michael Jarvis, highlighted that the ethos is directly fuelling the rise of paper mills, predatory journals and a sidelining of the peer review process that is making it more challenging to identify high quality publications (Jarvis, <span>2024</span>; Jarvis &amp; Williams, <span>2016</span>).</p><p>Professor Roland Seifert, the EiC of the oldest pharmacology journal <i>Naunyn-Schmiedebergs Arch Pharmacol</i> (<i>NSAP</i>) founded in 1873, gave a detailed account of their ongoing war against the fraudulent publications generated by paper mills. Prof. Seifert detailed a three-step approach used by <i>NSAP</i> to identify fake papers which included checking <i>NSAP</i> rejected and withdrawn manuscripts against published literature using text mining tools, comparing the author lists of rejected/withdrawn <i>NSAP</i> submissions with their subsequently published versions in other journals and finally manual verification that the submission is the same if the author lists differed extensively. In this way, <i>NSAP</i> evaluated 2056 papers rejected/withdrawn between 2015 and 2021, finding that 952 were published elsewhere. Eleven of these 952 had radically different author lists than the <i>NSAP</i> submitted versions, and 10 of these were ultimately deemed to be fake papers (Wittau et al., <span>2024</span>). Notably, the vast majority of the authors on these fake papers were Chinese highlighting paper mills as a geographic problem (Wittau &amp; Seifert, <span>2024</span>). Disappointingly, the journals that published the 10 fake papers have yet to take substantiative corrective action, highlighting that a massive change is necessary in how journals cooperate to maintain the scientific record. To combat paper mills, <i>NSAP</i> proposes the establishment of a database where all journals would submit their received manuscripts to enable cross-checking and flagging of potentially fraudulent papers.</p><p>The best way to prevent overt publication fraud is to detect it at its earliest stages. To this end, the EiCs of <i>Pathology Oncology Research</i> (Dr. József Tímár), <i>Physiology International</i> (Dr. Zoltan Benyó), <i>Pharmacological Research</i> (Professor Emilio Clementi) and the <i>European Journal of Mental Health</i> (Professor Dávid Beáta) detailed the criteria they use to screen submissions. Immediate warning signs of potential fraud include all of the authors on a manuscript having 0–2 previous publications, use of non-institutional email addresses, the claimed institute not having an easily identified homepage, study funding undefined yet the submission contains expensive experiments and if the authors cannot suggest potential reviewers for their work. To help validate author identity, it is suggested that ORCIDs as well as work email addresses should be required. At the level of the manuscript itself, plagiarism should be screened for stringently with 0% text overlap occurring in the results section and &lt;20% text overlap overall. Images should be checked for signs of manipulation and raw data such as uncut western blots submitted along with the manuscript. Additionally, only research that is ethically approved should be under consideration for publication that requires the submission of original internal review board (IRB) documents demonstrating study approval. Author contributions should also be declared using internationally recognized systems such as ‘Contributor Roles Taxonomy’ (CRediT) and the International Committee of Medical Journal Editors Acknowledgements criteria.</p><p>The process of peer review is integral to the maintenance of scientific integrity. A general consensus of the meeting participants was that the double-blind review process is optimal for unbiased assessment and should involve at least two expert reviewers. Recognizing the wide scope of their portfolio, it is recommended that journals develop a robust network of consulting editors. These editors, specialists in key subfields, can provide their expertise on an as-needed basis, ensuring high-quality and relevant evaluations.</p><p>A consensus view to emerge from this meeting was the need to foster a sense of community among authors, editors and reviewers. Indeed, if everyone has a direct stake in scientific integrity and is personally motivated to help maintain it, there is much less room for fraud to take root. This is especially relevant in the pharmacology research community that has a well-established history of requiring the reporting of clear and comprehensive reporting of research methodology and analysis (Jarvis, <span>2024</span>). Professor Orhan correctly identified that this begins on the institute level that have to do much more to promote an environment of scientific cooperation and knowledge sharing. He further proposed that specific education at the institute level in publication ethics could go a long way to curbing unintentional ethical lapses and greatly improve outcomes for both authors, journals and ultimately the scientific record.</p><p>Another crucial element in safeguarding scientific integrity is the continued support and development of society-affiliated journals as exemplified by ASPET, BPS and DGPT. These society-based journals benefit immensely from the interconnected community of members who regularly engage at society meetings and conferences. Such interactions facilitate a deeper understanding and familiarity with ongoing research in the field. When editors and reviewers are active participants in these scientific discussions, they gain first-hand insight into the nuances of the research and the reliability of the researchers themselves. This familiarity helps in making more informed decisions during the peer review process. Moreover, the society meetings serve as platforms for vibrant scientific debate, allowing potential issues and breakthroughs to be scrutinized collaboratively. By fostering a community that is both knowledgeable and engaged, society-affiliated journals inherently promote a culture of transparency and rigorous scholarly review, thereby enhancing the overall quality and credibility of published research. Additionally, these journals can further support the society's community-building efforts by publishing meeting proceedings (Murphy et al., <span>2022</span>; Whitehead et al., <span>2022</span>). This not only captures the spirit of the scientific debates held at these gatherings but also serves as a valuable archival resource that chronicles the progression of thought and discovery within the field.</p><p>Professor Zoltan Ungvari of <i>GeroScience</i> highlighted an innovative approach to build community within the journal's network. As part of the American Aging Association (AGE), <i>GeroScience</i> utilizes members with high scientific standing from AGE to serve as handling editors, thereby enhancing the quality and depth of the feedback provided to authors. The journal also has instituted a mentorship program where seasoned reviewers guide less experienced ones, promoting a rigorous review culture. This system has not only increased reviewer reliability but also achieved a remarkable 96% author satisfaction rate, demonstrating the efficacy of community-oriented approaches in scientific publishing.</p><p>Efforts to foster proactive engagement among junior scientists are a vital part of community-building within scientific societies. One particularly effective strategy highlighted by Professor Ungvari is the provision of incentives such as publication awards. These awards are given to junior scientists who author high-impact papers published in the society-affiliated journal. Additionally, award recipients are invited to attend the annual meeting of the society and are often recruited for the journal's peer reviewer training program. This involvement not only provides them with a platform to share their work and engage directly with leading figures in the field but also integrates them into the journal's operational processes, including open meetings held at the society's annual gatherings. Such initiatives strengthen the bond between the journal and the society while reinforcing the community as a whole. By supporting the development of emerging scientists in these ways, the journal and the society cultivate a rich environment of collaboration and scholarly exchange, enhancing the scientific community from the ground up.</p><p>Notwithstanding all emphasis on scientific integrity and all efforts to prevent publication of fraudulent studies, authors and editors must also cooperate to set the record straight and avoid a positive publication bias in a specific field (Skyschally et al., <span>2024</span>). Professor Gerd Heusch, EiC of <i>Basic Research in Cardiology</i> (<i>BRiC</i>), proposed that authors are encouraged to use a prospective, power analysis-based study design with appropriate randomization and blinding of investigators wherever possible. Editors should make sure that neutral studies and studies which contradict prior published data are published in equal right with positive, novel studies (Jarvis et al., <span>2023</span>).</p><p>In conclusion, the symposium at Semmelweis University marks a significant milestone in the ongoing battle against predatory journals and the broader challenges facing scientific publishing. The collaborative efforts discussed, and the strategies developed during the event underline a collective commitment to upholding scientific integrity. The measures outlined by the symposium's participants, from enhancing peer review to fostering transparency through society-affiliated journals and social media, set a path toward a more accountable and reliable scientific discourse. A key takeaway is the crucial need for non-predatory journals to form a united front, sharing resources, data and best practices to effectively combat the spread of unethical publications. This cooperation is essential not only for maintaining high standards within individual journals but also for fostering a global academic environment resistant to fraud and misconduct. As the academic community continues to evolve, the importance of robust review processes, community engagement and the implementation of innovative tools such as AI cannot be overstated. By continuing to engage, educate and innovate, we can ensure that scientific advancements remain a beacon of truth and progress.</p>\",\"PeriodicalId\":9262,\"journal\":{\"name\":\"British Journal of Pharmacology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":6.8000,\"publicationDate\":\"2024-06-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bph.16480\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"British Journal of Pharmacology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/bph.16480\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"British Journal of Pharmacology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bph.16480","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

Guzik强调了数据共享工具,如旨在让人类和计算机都能轻松访问原始数据的GO Fair、预印本服务器bioRxiv和medRxiv,以及作为开放存取大数据传播模式的英国生物库等资料库。他还谈到了人工智能在开放科学模式中的作用,并指出了人工智能的优点和缺点。他强调了人工智能的多方面优势,包括其速度和效率、减少人为分析偏差的潜力、增强模式识别、提高可重复性以及生成稳健的预测模型。讨论的缺点包括人工智能输出质量控制、知识产权和数据隐私问题、分析偏见的引入和延续以及人类用户批判性思维的削弱。尽管 "开放科学 "模式有多方面的好处,但《药理学研究与展望》(Pharmacology Research &amp; Perspectives)的EiC迈克尔-贾维斯(Michael Jarvis)博士强调,这种风气直接助长了造纸厂、掠夺性期刊的兴起,并使同行评审程序靠边站,从而增加了识别高质量出版物的难度(Jarvis,2024;Jarvis &amp; Williams,2016)。历史最悠久的药理学期刊《Naunyn-Schmiedebergs Arch Pharmacol》(NSAP)创刊于 1873 年,该期刊的 EiC 罗兰-塞弗特(Roland Seifert)教授详细介绍了他们正在与造纸厂产生的欺诈性出版物进行的斗争。Seifert教授详细介绍了NSAP识别虚假论文的三步方法,包括利用文本挖掘工具将NSAP退稿和撤稿与已发表的文献进行核对,比较NSAP退稿/撤稿投稿的作者名单及其随后在其他期刊上发表的版本,最后,如果作者名单差异较大,则人工验证投稿是否相同。通过这种方法,NSAP 评估了 2015 年至 2021 年期间被拒/撤稿的 2056 篇论文,发现其中 952 篇在其他地方发表。在这952篇论文中,有11篇的作者名单与NSAP提交的版本截然不同,其中10篇最终被认定为假论文(Wittau等人,2024年)。值得注意的是,这些假论文的绝大多数作者都是中国人,这凸显了造纸厂的地域性问题(Wittau &amp; Seifert, 2024)。令人失望的是,发表这 10 篇假论文的期刊尚未采取实质性的纠正措施,这凸显出有必要对期刊合作维护科学记录的方式进行重大变革。为了打击论文加工厂,国家自然科学规划建议建立一个数据库,让所有期刊都能提交所收到的稿件,以便进行交叉核对,并对潜在的造假论文进行标记。为此,《病理学肿瘤学研究》(József Tímár博士)、《国际生理学》(Zoltan Benyó博士)、《药理学研究》(Emilio Clementi教授)和《欧洲心理健康杂志》(Dávid Beáta教授)的EiC详细介绍了他们筛选投稿的标准。潜在欺诈的直接警告信号包括:稿件的所有作者以前发表过0-2篇论文;使用非本机构的电子邮件地址;所声称的机构没有易于识别的主页;研究经费未确定,但所投稿件包含昂贵的实验;作者无法为其作品推荐潜在审稿人。为帮助验证作者身份,建议要求提供 ORCID 和工作电子邮件地址。在稿件本身层面,应严格筛查抄袭行为,结果部分的文字重叠率应为 0%,整体文字重叠率应为 20%。应检查图片是否有被篡改的痕迹,原始数据(如未剪切的 Western 印迹)应与稿件一起提交。此外,只有获得伦理批准的研究才能考虑发表,这需要提交内部审查委员会(IRB)的原始文件,证明研究获得批准。作者的贡献也应使用国际公认的系统进行声明,如 "贡献者角色分类"(CRediT)和国际医学期刊编辑委员会致谢标准。与会者普遍认为,双盲审稿程序是进行公正评估的最佳方式,至少应有两名专家审稿人参与。鉴于期刊的业务范围广泛,建议期刊建立一个强大的顾问编辑网络。这些编辑都是关键子领域的专家,可以根据需要提供专业知识,确保评估的高质量和相关性。本次会议达成的一个共识是,需要在作者、编辑和审稿人之间培养集体意识。 总之,在塞梅尔维斯大学举行的研讨会标志着与掠夺性期刊的持续斗争以及科学出版面临的更广泛挑战中的一个重要里程碑。会议期间讨论的合作努力和制定的战略彰显了维护科学诚信的集体承诺。研讨会与会者概述的措施,从加强同行评审到通过社会附属期刊和社交媒体提高透明度,为实现更负责任、更可靠的科学话语指明了道路。会议的一个重要启示是,非掠夺性期刊亟需结成统一战线,共享资源、数据和最佳实践,以有效打击不道德出版物的传播。这种合作不仅对保持单个期刊的高标准至关重要,而且对营造一个抵制欺诈和不端行为的全球学术环境也至关重要。随着学术界的不断发展,健全的审稿流程、社区参与以及人工智能等创新工具的应用的重要性无论怎样强调都不为过。通过继续参与、教育和创新,我们可以确保科学进步始终是真理和进步的灯塔。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Scientific integrity in the era of predatory journals: Insights from an editors in chief symposium

In recent years, the academic community has faced a growing threat from predatory journals. These are publications that prioritize profit over quality scholarship and compromise the integrity of scientific discourse. Predatory journals often bypass rigorous peer review processes, creating a platform for substandard and sometimes fraudulent research. The proliferation of such journals not only undermines trust in scientific publications but also poses serious challenges for researchers who are trying to responsibly share their findings.

Recognizing these pressing issues, Semmelweis University held a symposium on 16 November 2023, titled ‘Science Integrity in the Era of Predator Journals’. This event was a response to growing concerns about academic publishing. It brought together editors in chief (EiCs) from 14 top journals to discuss critical topics. These included using AI to detect publication fraud, the identification of AI-generated papers, combating paper mills, the necessity of robust submission and review processes and the importance of author identity and conflict of interest vetting.

This editorial offers a thorough summary of the symposium's discussions. It highlights the collaborative efforts to improve publication standards and reinforce ethical practices in scientific research. Through shared insights and strategies, the participants tackled the complex challenges posed by predatory journals, setting a course for sustained integrity in the dissemination of scientific knowledge.

Professor Péter Ferdinandy, the EiC of the British Journal of Pharmacology (BJP) and host of the event, presented how he plans to continue the long tradition of BJP excellence while improving overall publication quality as well as the experience of both authors and editors. In this regard, steps have been taken to simplify the BJP publication guidelines and improve turnaround times at every step of the review and publication process (Papapetropoulos et al., 2023). He also highlighted that BJP editors in partnership with the BJP publisher Wiley are taking aggressive steps to combat publication fraud. These steps have involved the development of an efficient pipeline to handle ethics investigations as well as the retention of a consulting editor dedicated to matters of research integrity. As a result, ethical concerns raised internally or by third parties are dealt with in a much timelier manner with corrective action being rapidly implemented where necessary.

The EiC of the British Journal of Clinical Pharmacology (BJCP—a sister journal of BJP also published by Wiley), Professor Serge Cremers, delved into many issues surrounding the maintenance of publication integrity. As the BJCP deals with many clinical studies, a strong emphasis was placed on resolving the inherent conflicts of interest that arise between the economics of drug development and patient well-being that may bias the publication of clinical trial results. The BJCP requires all submissions to strongly adhere to good clinical practice (GCP) guidelines, have internal review board (IRB) approval and disclose the identity of the physician conducting the trial. The BJCP also utilizes AI-powered systems provided by Wiley for the detection of plagiarism, image manipulation and other forms of fraud. However, BJCP still heavily relies on its editors and reviewers to detect fraud and admits that despite all the safeguards in-place, intercepting all forms of deceit is not perfect.

The EiC of Pharmacology Research & Perspectives (PR&P—a collaborative Open Access journal of the British Pharmacology Society [BPS], the American Society for Pharmacology and Experimental Therapeutics and Wiley), Michael Jarvis, highlighted ongoing strategic priorities of publishing pharmacological methods, research replication studies and negative research findings and providing a forum for early career researchers. While only in its 11th year, PR&P provides an important, geographically inclusive, venue for publication of scientifically rigorous papers that directly address issues of research reliability (Jarvis et al., 2023). Like BJP and BJCP, all papers and data submitted to PR&P are initially screened using Wiley's AL-powered manuscript integrity system.

Professor Tomasz Guzik, the EiC of Cardiovascular Research, introduced the meeting attendees to the concepts of ‘Open Science’. This is an initiative that strives to improve the trust and access to scientific knowledge by implementing ‘open’ processes at every step of the way from data generation and analysis through publication and dissemination. Pillars of this initiative are open data, open access publication, open source software, open evaluation and open educational resources. This model was also avidly supported by the EiC of Oral Radiology, Professor Kaan Orhan, who emphasized the need for detailed methodological reporting as well as raw data and source code sharing. Prof. Guzik highlighted data sharing tools such as GO Fair that aims to make raw data easily accessible to both humans and computers, the preprint servers bioRxiv and medRxiv and repositories such as the UK Biobank as a model for open access big data dissemination. He also tackled the role of AI within the open science model, addressing the good and the bad. The advantages of AI highlighted were manifold including its speed and efficiency, potential to reduce human-led analysis bias, enhanced pattern recognition, improved reproducibility and generation of robust predictive models. The drawbacks discussed included AI output quality control, intellectual property and data privacy issues, the introduction and perpetuation of analysis biases and the erosion of human user critical thinking. Although there are manifold benefits to the ‘Open Science’ model, the EiC of Pharmacology Research & Perspectives, Dr. Michael Jarvis, highlighted that the ethos is directly fuelling the rise of paper mills, predatory journals and a sidelining of the peer review process that is making it more challenging to identify high quality publications (Jarvis, 2024; Jarvis & Williams, 2016).

Professor Roland Seifert, the EiC of the oldest pharmacology journal Naunyn-Schmiedebergs Arch Pharmacol (NSAP) founded in 1873, gave a detailed account of their ongoing war against the fraudulent publications generated by paper mills. Prof. Seifert detailed a three-step approach used by NSAP to identify fake papers which included checking NSAP rejected and withdrawn manuscripts against published literature using text mining tools, comparing the author lists of rejected/withdrawn NSAP submissions with their subsequently published versions in other journals and finally manual verification that the submission is the same if the author lists differed extensively. In this way, NSAP evaluated 2056 papers rejected/withdrawn between 2015 and 2021, finding that 952 were published elsewhere. Eleven of these 952 had radically different author lists than the NSAP submitted versions, and 10 of these were ultimately deemed to be fake papers (Wittau et al., 2024). Notably, the vast majority of the authors on these fake papers were Chinese highlighting paper mills as a geographic problem (Wittau & Seifert, 2024). Disappointingly, the journals that published the 10 fake papers have yet to take substantiative corrective action, highlighting that a massive change is necessary in how journals cooperate to maintain the scientific record. To combat paper mills, NSAP proposes the establishment of a database where all journals would submit their received manuscripts to enable cross-checking and flagging of potentially fraudulent papers.

The best way to prevent overt publication fraud is to detect it at its earliest stages. To this end, the EiCs of Pathology Oncology Research (Dr. József Tímár), Physiology International (Dr. Zoltan Benyó), Pharmacological Research (Professor Emilio Clementi) and the European Journal of Mental Health (Professor Dávid Beáta) detailed the criteria they use to screen submissions. Immediate warning signs of potential fraud include all of the authors on a manuscript having 0–2 previous publications, use of non-institutional email addresses, the claimed institute not having an easily identified homepage, study funding undefined yet the submission contains expensive experiments and if the authors cannot suggest potential reviewers for their work. To help validate author identity, it is suggested that ORCIDs as well as work email addresses should be required. At the level of the manuscript itself, plagiarism should be screened for stringently with 0% text overlap occurring in the results section and <20% text overlap overall. Images should be checked for signs of manipulation and raw data such as uncut western blots submitted along with the manuscript. Additionally, only research that is ethically approved should be under consideration for publication that requires the submission of original internal review board (IRB) documents demonstrating study approval. Author contributions should also be declared using internationally recognized systems such as ‘Contributor Roles Taxonomy’ (CRediT) and the International Committee of Medical Journal Editors Acknowledgements criteria.

The process of peer review is integral to the maintenance of scientific integrity. A general consensus of the meeting participants was that the double-blind review process is optimal for unbiased assessment and should involve at least two expert reviewers. Recognizing the wide scope of their portfolio, it is recommended that journals develop a robust network of consulting editors. These editors, specialists in key subfields, can provide their expertise on an as-needed basis, ensuring high-quality and relevant evaluations.

A consensus view to emerge from this meeting was the need to foster a sense of community among authors, editors and reviewers. Indeed, if everyone has a direct stake in scientific integrity and is personally motivated to help maintain it, there is much less room for fraud to take root. This is especially relevant in the pharmacology research community that has a well-established history of requiring the reporting of clear and comprehensive reporting of research methodology and analysis (Jarvis, 2024). Professor Orhan correctly identified that this begins on the institute level that have to do much more to promote an environment of scientific cooperation and knowledge sharing. He further proposed that specific education at the institute level in publication ethics could go a long way to curbing unintentional ethical lapses and greatly improve outcomes for both authors, journals and ultimately the scientific record.

Another crucial element in safeguarding scientific integrity is the continued support and development of society-affiliated journals as exemplified by ASPET, BPS and DGPT. These society-based journals benefit immensely from the interconnected community of members who regularly engage at society meetings and conferences. Such interactions facilitate a deeper understanding and familiarity with ongoing research in the field. When editors and reviewers are active participants in these scientific discussions, they gain first-hand insight into the nuances of the research and the reliability of the researchers themselves. This familiarity helps in making more informed decisions during the peer review process. Moreover, the society meetings serve as platforms for vibrant scientific debate, allowing potential issues and breakthroughs to be scrutinized collaboratively. By fostering a community that is both knowledgeable and engaged, society-affiliated journals inherently promote a culture of transparency and rigorous scholarly review, thereby enhancing the overall quality and credibility of published research. Additionally, these journals can further support the society's community-building efforts by publishing meeting proceedings (Murphy et al., 2022; Whitehead et al., 2022). This not only captures the spirit of the scientific debates held at these gatherings but also serves as a valuable archival resource that chronicles the progression of thought and discovery within the field.

Professor Zoltan Ungvari of GeroScience highlighted an innovative approach to build community within the journal's network. As part of the American Aging Association (AGE), GeroScience utilizes members with high scientific standing from AGE to serve as handling editors, thereby enhancing the quality and depth of the feedback provided to authors. The journal also has instituted a mentorship program where seasoned reviewers guide less experienced ones, promoting a rigorous review culture. This system has not only increased reviewer reliability but also achieved a remarkable 96% author satisfaction rate, demonstrating the efficacy of community-oriented approaches in scientific publishing.

Efforts to foster proactive engagement among junior scientists are a vital part of community-building within scientific societies. One particularly effective strategy highlighted by Professor Ungvari is the provision of incentives such as publication awards. These awards are given to junior scientists who author high-impact papers published in the society-affiliated journal. Additionally, award recipients are invited to attend the annual meeting of the society and are often recruited for the journal's peer reviewer training program. This involvement not only provides them with a platform to share their work and engage directly with leading figures in the field but also integrates them into the journal's operational processes, including open meetings held at the society's annual gatherings. Such initiatives strengthen the bond between the journal and the society while reinforcing the community as a whole. By supporting the development of emerging scientists in these ways, the journal and the society cultivate a rich environment of collaboration and scholarly exchange, enhancing the scientific community from the ground up.

Notwithstanding all emphasis on scientific integrity and all efforts to prevent publication of fraudulent studies, authors and editors must also cooperate to set the record straight and avoid a positive publication bias in a specific field (Skyschally et al., 2024). Professor Gerd Heusch, EiC of Basic Research in Cardiology (BRiC), proposed that authors are encouraged to use a prospective, power analysis-based study design with appropriate randomization and blinding of investigators wherever possible. Editors should make sure that neutral studies and studies which contradict prior published data are published in equal right with positive, novel studies (Jarvis et al., 2023).

In conclusion, the symposium at Semmelweis University marks a significant milestone in the ongoing battle against predatory journals and the broader challenges facing scientific publishing. The collaborative efforts discussed, and the strategies developed during the event underline a collective commitment to upholding scientific integrity. The measures outlined by the symposium's participants, from enhancing peer review to fostering transparency through society-affiliated journals and social media, set a path toward a more accountable and reliable scientific discourse. A key takeaway is the crucial need for non-predatory journals to form a united front, sharing resources, data and best practices to effectively combat the spread of unethical publications. This cooperation is essential not only for maintaining high standards within individual journals but also for fostering a global academic environment resistant to fraud and misconduct. As the academic community continues to evolve, the importance of robust review processes, community engagement and the implementation of innovative tools such as AI cannot be overstated. By continuing to engage, educate and innovate, we can ensure that scientific advancements remain a beacon of truth and progress.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.40
自引率
12.30%
发文量
270
审稿时长
2.0 months
期刊介绍: The British Journal of Pharmacology (BJP) is a biomedical science journal offering comprehensive international coverage of experimental and translational pharmacology. It publishes original research, authoritative reviews, mini reviews, systematic reviews, meta-analyses, databases, letters to the Editor, and commentaries. Review articles, databases, systematic reviews, and meta-analyses are typically commissioned, but unsolicited contributions are also considered, either as standalone papers or part of themed issues. In addition to basic science research, BJP features translational pharmacology research, including proof-of-concept and early mechanistic studies in humans. While it generally does not publish first-in-man phase I studies or phase IIb, III, or IV studies, exceptions may be made under certain circumstances, particularly if results are combined with preclinical studies.
期刊最新文献
Vortioxetine reduces the development of pain-related behaviour in a knee osteoarthritis model in rats: Involvement of nerve growth factor (NGF) down-regulation Selective modulation of epileptic tissue by an adenosine A3 receptor-activating drug Contribution of T-type calcium channel isoforms to cold and mechanical sensitivity in naïve and oxaliplatin-treated mice of both sexes Mitigating off-target effects of small RNAs: conventional approaches, network theory and artificial intelligence Immune regulatory and anti-resorptive activities of tanshinone IIA sulfonate attenuates rheumatoid arthritis in mice
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1